Evidence map›Paper›PMID 18332221›Full record

ArticleThe Journal of cell biology2008

Myoblasts and macrophages share molecular components that contribute to cell-cell fusion.

Kostandin V Pajcini, Jason H Pomerantz, Ozan Alkan, Regis Doyonnas, Helen M Blau

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Reduced Expression of Septin7 Hinders Skeletal Muscle Regeneration.International journal of molecular sciences · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The fusogenic synapse at a glance.Journal of cell science · 2019
    Review
  12. Article
  13. Adult stem cells at work: regenerating skeletal muscle.Cellular and molecular life sciences : CMLS · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kostandin V PajciniDepartment of Microbiology & Immunology, Baxter Laboratory in Genetic Pharmacology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jason H Pomerantz
Ozan Alkan
Regis Doyonnas
Helen M Blau
Baxter (United States) · USStanford University · USUniversity of California, San Francisco · US

Funding

MOLECULAR BASIS OF HOST-PARASITE INTERACTIONT32AI007328 · NIAID · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 1987 to 2026
$11.9M
Stem Cells for Brain and BrawnR01AG020961 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2002 to 2019
$5.0M
ACTIVATORS OF MUSCLE GENESR01AG009521 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1990 to 2014
$4.7M
TRAINING IN NEONATAL BIOLOGYT32HD007249 · NICHD · STANFORD UNIVERSITY · PI STEVENSON, DAVID K · 1985 to 2013
$4.4M
Small Molecule Imaging of Protease ActivityR01EB005011 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2005 to 2013
$3.0M
REGULATION OF MUSCLE DEVELOPMENTR01HD018179 · NICHD · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1985 to 2007
$2.7M
ACTIVATORS OF HUMAN MUSCLE GENESR37AG009521 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1995 to 2004
$2.3M
Regulator of Adult Stem Cell FateR01AG024987 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2004 to 2008
$1.7M
ACF HHS AF051678NIAID NIH HHS 5T32 AI07328NIAID NIH HHS T32 AI007328NIA NIH HHS AG009521NIA NIH HHS AG020961NIA NIH HHS AG024987NIA NIH HHS R01 AG009521NIA NIH HHS R01 AG020961NIA NIH HHS R01 AG024987NIA NIH HHS R37 AG009521NIBIB NIH HHS EB005011NIBIB NIH HHS R01 EB005011NICHD NIH HHS 5T32 HD007249NICHD NIH HHS HD018179NICHD NIH HHS R01 HD018179NICHD NIH HHS T32 HD007249
6 · The paper itself

Abstract

Cell-cell fusion is critical to the normal development of certain tissues, yet the nature and degree of conservation of the underlying molecular components remains largely unknown. Here we show that the two guanine-nucleotide exchange factors Brag2 and Dock180 have evolutionarily conserved functions in the fusion of mammalian myoblasts. Their effects on muscle cell formation are distinct and are a result of the activation of the GTPases ARF6 and Rac, respectively. Inhibition of ARF6 activity results in a lack of physical association between paxillin and beta(1)-integrin, and disruption of paxillin transport to sites of focal adhesion. We show that fusion machinery is conserved among distinct cell types because Dock180 deficiency prevented fusion of macrophages and the formation of multinucleated giant cells. Our results are the first to demonstrate a role for a single protein in the fusion of two different cell types, and provide novel mechanistic insight into the function of GEFs in the morphological maturation of multinucleated cells.

Indexed as

ADP-Ribosylation Factor 6ADP-Ribosylation FactorsAnimalsCell AdhesionCell CommunicationCell FusionCell LineFocal AdhesionsGiant CellsGuanine Nucleotide Exchange FactorsIntegrin beta1MacrophagesMiceMyoblastsNeuropeptidesPaxillinADP-Ribosylation Factor 6ADP-Ribosylation FactorsARF6 protein, humanArf6 protein, mouseArf6 protein, ratDock180 protein, mouseDOCK180 protein, ratGuanine Nucleotide Exchange FactorsIntegrin beta1IQSEC1 protein, humanNeuropeptidesPaxillinrac1 GTP-Binding ProteinRac1 protein, mouserac GTP-Binding ProteinsRNA, Small Interfering

Identifiers

PMID18332221
PMCPMC2265408
OpenAlexW2134379576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.